Topics

PreveCeutical focuses on the development of preventive and curative therapies

12:16 EDT 30 Apr 2019 | Proactive Investors

The health sciences company has five research and development programs, including gene therapy, its Sol-gel program for nose-to-brain delivery of medical compounds including cannabinoids, as well as non-addictive analgesic peptides as a replacement for morphine, fentanyl and oxycodone

Original Article: PreveCeutical focuses on the development of preventive and curative therapies

NEXT ARTICLE

More From BioPortfolio on "PreveCeutical focuses on the development of preventive and curative therapies"

Quick Search

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...